Advertisement
ADVANCED SEARCH
© 2010
Canadian Medical Association
or its licensors
All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association.
This Article
Abstract
Full Text
Submit a response
Services
Email this article to a friend
Alert me to new issues of the journal
Efficacy and safety of unfractionated heparin versus enoxaparin: a pooled analysis of ASSENT-3 and -3 PLUS data
CMAJ Armstrong et al. 174: 1421
Online Appendices
Files in this Data Supplement:
Appendix 1: Baseline characteristics of patients in the ASSENT-3 PLUS and ASSENT-3 trials, by treatment group
Appendix 2:Kaplan–Meier curves for myocardial reinfarction (re-MI) according to patients’ revascularization status
Appendix 3:Kaplan–Meier curves for major bleeding according to patients’ revascularization status
This Article
Abstract
Full Text
Submit a response
Services
Email this article to a friend
Alert me to new issues of the journal